A drug repurposing screen identifies altiratinib as a selective inhibitor of a key regulatory splicing kinase and a potential therapeutic for toxoplasmosis and malariaChristopher Swale, Mohamed‐Ali Hakimi|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 1
Hydra domain drives SNF2L multimerization and marks ISWI diversification in parasitesBelen Pachano, Christopher Swale|bioRxiv (Cold Spring Harbor Laboratory)|2025Cited by 0